Table 3.
Results of subgroups analyses
| Groups | Categories | Number of studies | Effect estimate | P | Heterogeneity with groups (I2) | Pheterogeneity |
|---|---|---|---|---|---|---|
| Location | North America | 7 | 0.47 (0.33, 0.68) | < 0.001 | 53% | 0.040 |
| Europe | 5 | 0.47 (0.18, 1.22) | 0.120 | 89% | < 0.001 | |
| Follow-up period | ≤ 5 years | 2 | 0.65 (0.50, 0.84) | 0.001 | 4% | 0.310 |
| > 5 years | 4 | 0.48 (0.17, 1.31) | 0.150 | 71% | 0.020 | |
| Study design | Case control | 6 | 0.55 (0.25, 1.20) | 0.130 | 87% | < 0.001 |
| Cohort | 6 | 0.55 (0.44, 0.69) | < 0.001 | 36% | 0.160 | |
| Sample size | ≤ 1000 | 5 | 0.32 (0.11, 0.88) | 0.030 | 83% | < 0.001 |
| > 1000 | 7 | 0.57 (0.39, 0.82) | 0.003 | 69% | 0.003 | |
| Adjusted confounders | Multivariable-adjusted | 10 | 0.46 (0.30, 0.71) | < 0.001 | 81% | < 0.001 |
| Age-gender adjusted | 2 | 0.09 (0.05, 0.17) | < 0.001 | 0% | 0.340 | |
| Unadjusted | 7 | 0.57 (0.41, 0.81) | 0.002 | 59% | 0.020 | |
| Quality assessment | High | 6 | 0.59 (0.47–0.74) | < 0.001 | 31% | 0.200 |
| Moderate | 4 | 0.62 (0.18–2.14) | 0.440 | 91% | < 0.001 |